New drug cocktail shows promise for tough stomach cancer
NCT ID NCT03223376
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding fruquintinib to standard chemotherapy (paclitaxel) helps people with advanced stomach cancer live longer. It included 703 patients whose cancer had worsened after initial treatment. The goal was to see if the combination improves survival and slows cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huchison Medi Pharma Investigational site
Nanjing, Jiangsu, 210000, China
-
Hutchison Medi Pharma Invesigational sites
Hefei, Anhui, 230000, China
-
Hutchison Medi Pharma Investigational Site
Guangzhou, Guangdong, 510030, China
-
Hutchison Medi Pharma Investigational site
Harbin, Heilongjiang, 150081, China
-
Hutchison Medi Pharma Investigational site
Shanghai, 200125, China
-
Hutchison Medi Pharma Investigational sites
Hangzhou, Zhejiang, 310000, China
-
Hutchison Medi Pharma Investigational sites
Beijing, 100142, China